"10.1371_journal.ppat.1000055","plos pathogens","2008-05-02T00:00:00Z","Robert De Rose; Caroline S Fernandez; Miranda Z Smith; C Jane Batten; Sheilajen Alcântara; Vivienne Peut; Erik Rollman; Liyen Loh; Rosemarie D Mason; Kim Wilson; Matthew G Law; Amanda J Handley; Stephen J Kent","Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia; National Serology Reference Laboratory, Fitzroy, Victoria, Australia; National Centre for HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, New South Wales, Australia; Opal Therapeutics Pty Ltd, Melbourne, Victoria, Australia","¤Medicines Development Ltd, Melbourne, Victoria, Australia","SJK spun out a venture capital–backed biotechnology start-up company, OPAL Therapeutics Pty Ltd, to pursue this technology towards clinical trials. SJK, CJB and the University of Melbourne hold shares in this company. AJH has been an employee of OPAL Therapeutics.","2008","05","Robert De Rose","RDR",13,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
